{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T12:30:19Z","timestamp":1787056219038,"version":"build-2736575974"},"reference-count":13,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100005601","name":"CLL Global Research Foundation","doi-asserted-by":"publisher","award":["AWD -115284"],"award-info":[{"award-number":["AWD -115284"]}],"id":[{"id":"10.13039\/100005601","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005601","name":"CLL Global Research Foundation","doi-asserted-by":"publisher","award":["AWD-116510"],"award-info":[{"award-number":["AWD-116510"]}],"id":[{"id":"10.13039\/100005601","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advances in Biological Regulation"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.jbior.2026.101170","type":"journal-article","created":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T07:12:34Z","timestamp":1780557154000},"page":"101170","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Avoidance of immune mediated tumor rejection by cancer cells"],"prefix":"10.1016","volume":"101","author":[{"given":"Yuri","family":"Pekarsky","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3788-1457","authenticated-orcid":false,"given":"Carlo M.","family":"Croce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"26","key":"10.1016\/j.jbior.2026.101170_bib1","doi-asserted-by":"crossref","first-page":"E1695","DOI":"10.1073\/pnas.1201516109","article-title":"Nanoparticle-based therapy in an in vivo microRNA-155 (miR-155)-dependent mouse model of lymphoma","volume":"109","author":"Babar","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1016\/j.jbior.2026.101170_bib2","doi-asserted-by":"crossref","first-page":"15524","DOI":"10.1073\/pnas.242606799","article-title":"Frequent deletion and deregulation of micro-RNA genes miR-15 and miR-16 at 13q14 in chronic lymphocytic leukemia","volume":"99","author":"Calin","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1016\/j.jbior.2026.101170_bib3","doi-asserted-by":"crossref","first-page":"13944","DOI":"10.1073\/pnas.0506654102","article-title":"miR-15 and miR-16 induce apoptosis by targeting BCL2","volume":"102","author":"Cimino","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jbior.2026.101170_bib4","doi-asserted-by":"crossref","unstructured":"Costinean et al., Pre-B cell proliferation and lymphoblastic leukemia\/high-grade lymphoma in E\u03bc-miR155 transgenic mice. Proc. Natl. Acad. Sci. USA 103; (18) 7024-7019.","DOI":"10.1073\/pnas.0602266103"},{"key":"10.1016\/j.jbior.2026.101170_bib5","doi-asserted-by":"crossref","first-page":"5914","DOI":"10.1158\/0008-5472.CAN-16-1248","article-title":"Finally an apoptosis targeting therapeutic for cancer","volume":"76","author":"Croce","year":"2016","journal-title":"Cancer Res."},{"key":"10.1016\/j.jbior.2026.101170_bib6","doi-asserted-by":"crossref","first-page":"10436","DOI":"10.1128\/JVI.00752-08","article-title":"Epstein-barr virus-induced miR-155 attenuates NF-\u03baB signaling and stabilizes latent virus persistence","volume":"82","author":"Lu","year":"2008","journal-title":"J. Virol."},{"issue":"4","key":"10.1016\/j.jbior.2026.101170_bib7","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.3390\/jcm14041200","article-title":"Advancements in melanoma treatment: a review of PD-1 inhibitors, T-VEC, mRNA vaccines, and tumor-infiltrating lymphocyte therapy in an evolving landscape of immunotherapy","volume":"14","author":"Mehta","year":"2025","journal-title":"J. Clin. Med."},{"issue":"19","key":"10.1016\/j.jbior.2026.101170_bib9","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2536375123","article-title":"MiR-155driven loss of ICOSL and SOCS10 in EBV+ gastric cancers renders abundant cytotoxic T cells ineffective, enabling immune evasion","volume":"123","author":"Nuovo","year":"2026","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1016\/j.jbior.2026.101170_bib8","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/s41392-025-02273-0","article-title":"Nasopharyngeal carcinoma: a model cancer to understand tumor rejection","volume":"10","author":"Nuovo","year":"2025","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.jbior.2026.101170_bib10","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/s41416-020-01048-4","article-title":"Cytotoxic CD8+ T cells in cancer and cancer immunotherapy","volume":"124","author":"Raskov","year":"2021","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.jbior.2026.101170_bib11","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.cell.2017.01.017","article-title":"Primary, adaptive, and acquired resistance to cancer immunotherapy","volume":"168","author":"Sharma","year":"2017","journal-title":"Cell"},{"issue":"29","key":"10.1016\/j.jbior.2026.101170_bib12","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2408649121","article-title":"MiR-155-targeted IcosL controls tumor rejection","volume":"121","author":"Tili","year":"2024","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"16","key":"10.1016\/j.jbior.2026.101170_bib13","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2422615122","article-title":"miR-155 impairs ICOSL and MHC-I expression in DLBCL lymphomas","volume":"122","author":"Tili","year":"2025","journal-title":"Proc. Natl. Acad. Sci. USA"}],"container-title":["Advances in Biological Regulation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212492626000278?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212492626000278?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T11:49:57Z","timestamp":1787053797000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212492626000278"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":13,"alternative-id":["S2212492626000278"],"URL":"https:\/\/doi.org\/10.1016\/j.jbior.2026.101170","relation":{},"ISSN":["2212-4926"],"issn-type":[{"value":"2212-4926","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Avoidance of immune mediated tumor rejection by cancer cells","name":"articletitle","label":"Article Title"},{"value":"Advances in Biological Regulation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbior.2026.101170","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"101170"}}